Publication: Development of an amperometric immunosensor for the determination of methamphetamine in urine
Issued Date
2002-12-01
Resource Type
ISSN
10242422
Other identifier(s)
2-s2.0-0036904456
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Biocatalysis and Biotransformation. Vol.20, No.6 (2002), 397-403
Suggested Citation
Kavinyanee Luangaram, Dolurdee Boonsua, Sarisak Soontornchai, Chamras Promptmas Development of an amperometric immunosensor for the determination of methamphetamine in urine. Biocatalysis and Biotransformation. Vol.20, No.6 (2002), 397-403. doi:10.1080/1024242021000058685 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/20018
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Development of an amperometric immunosensor for the determination of methamphetamine in urine
Other Contributor(s)
Abstract
An amperometric immunosensor in the competitive format was developed for the detection of methamphetamine in urine. The electrodes consisted of carbon paste and Ag/AgCl screen printed on heat sealing film, respectively, and of monoclonal lanti-methamphetamine antibody as the biorecognition element. Optimum amounts of methamphetamine-N-bovine serum albumin conjugate, monoclonal antibody and alkaline phosphatase-goat anti-mouse immunoglobulin G were 20, 10 ng and 1:10,000 dilution in 10 μl each, respectively. Methamphetamine was detected by the conversion of p-aminophenyl phosphate to electroactive p-aminophenol in the range of 200 ng/ml (lower detection limit) to 1,500 ng/ml methamphetamine in a nearly linear dose response curve. Within amphetamine concentrations of 0-1,500 ng/ml cross-reaction with methamphethamine was not observed. Working with urine samples spiked with methamphetamine, the accuracy and precision of the assay were 91.5-104.4% and 15.8-24.4%, respectively. This is a proof of concept in the clinical perspective for an amperometric immunosensor whose electrodes are amenable to future mass production.